Calcium channel blockers

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S252130, C514S255030, C514S255040, C514S613000, C514S617000, C514S618000, C514S310000, C514S255030

Reexamination Certificate

active

06951860

ABSTRACT:
The invention involves the identification of a family of compounds which block calcium channels. The compounds can be formulated in pharmaceutical carriers and administered to subjects. The compounds are useful for treating disorders associated with calcium channel activity, such as, cardiovascular diseases, for example hypertension, congestive heart failure, arrhythmia and angina.

REFERENCES:
patent: 4550116 (1985-10-01), Soto et al.
patent: 4593033 (1986-06-01), Hartman et al.
patent: 4596805 (1986-06-01), Jiang
patent: 4640930 (1987-02-01), Mohacsi et al.
patent: 4654353 (1987-03-01), Alker et al.
patent: 4742069 (1988-05-01), Jaunin et al.
patent: 4758669 (1988-07-01), Johnson et al.
patent: 4791117 (1988-12-01), Press
patent: 4829076 (1989-05-01), Szilagyi et al.
patent: 4847273 (1989-07-01), Jaunin et al.
patent: 4918073 (1990-04-01), Riiger et al.
patent: 4918074 (1990-04-01), Tsuda et al.
patent: 4959359 (1990-09-01), Mohacsi et al.
patent: 4988713 (1991-01-01), Frigerio et al.
patent: 4992432 (1991-02-01), Mohacsi et al.
patent: 4994612 (1991-02-01), Jaunin et al.
patent: 5017586 (1991-05-01), Schlager
patent: 5025010 (1991-06-01), Oekonomopulos et al.
patent: 5034395 (1991-07-01), Tamada et al.
patent: 5036098 (1991-07-01), Kimura et al.
patent: 5039674 (1991-08-01), Fujikura et al.
patent: 5070088 (1991-12-01), Atwal
patent: 5071844 (1991-12-01), Alker et al.
patent: 5106845 (1992-04-01), Carr et al.
patent: 5132106 (1992-07-01), Tuloup et al.
patent: 5134139 (1992-07-01), Kawai et al.
patent: 5135936 (1992-08-01), Adams et al.
patent: 5144029 (1992-09-01), Ward et al.
patent: 5198433 (1993-03-01), Palfreyman et al.
patent: 5276026 (1994-01-01), Barrish et al.
patent: 5281592 (1994-01-01), Ozeki et al.
patent: 5344830 (1994-09-01), Mills et al.
patent: 5360809 (1994-11-01), Axelsson et al.
patent: 5387592 (1995-02-01), Bradbury et al.
patent: 5496815 (1996-03-01), Ozeki et al.
patent: 5514693 (1996-05-01), Cozzi et al.
patent: 5607939 (1997-03-01), Kato et al.
patent: 5623051 (1997-04-01), Catterall et al.
Gialdi et al., Abstract to CA 56:4664g.
McMurry, John, Editor of Second Edition, Organic Chemistry, 1984, pp. 742-746.
Protiva, et al. of CZ 105,590 of CA59:10010f, Nov. 15, 1962.
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 9th Edition, pp. 767-774, 1996.
Gialdi, et al.,Chemical Abstracts, Mar. 8, 1962, 4664g, vol. 56, No. 5, The American Chemical Society.
Fujita, M. et al, “Synthesis and Ca2+Antagonistic Activity of 2-[2-[(Aminoalkyl)oxy]-5-methoxyphenyl]-3,4-dihydro-4-methyl-3-oxo-2H-1,4-benzo-thiazines”,J. Med. Chem., 1990, pp. 1898-1905, vol. 33, American Chemical Society.
Yamamoto, K, et al., “Novel Calcium Antagonists. Synthesis and Structure-Activity Relationship Studies of Benzothiazoline Derivatives”,J. Med. Chem., 1988, pp. 919-930, vol. 31, American Chemical Society.
Jilek, J.; et al., “Preparation of new antimicrobial (phenylthio)benzylamines”,Chemical AbstractsAccession No. 1992:612134 (Abstract only).
Jilek, J., et al., “Potential antidepressasnts: 2-(methyoxy- and hydroxyphenylthio)benzylamines as selective inhibitors of 5-hydroxytryptamine re-uptake in the brain”,Chemical AbstractsAccession No. 1990:458496 (Abstract only).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Calcium channel blockers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3440367

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.